** Shares of sleep apnea device maker Inspire Medical Systems INSP.N slump 31% to $90.31 premarket
** Co late on Monday lowered its 2025 sales forecast to between $900 million and $910 million, compared with its prior view of $940 million to $955 million
** INSP also cut its 2025 EPS to the range of 40 cents to 50 cents, compared to previous range of $2.20 to $2.30 per share
** J.P.Morgan analyst Robbie Marcus said "it’s frustrating to see a negative revision of this magnitude after original 2025E guidance was already framed as being conservative to reflect conservatism around Inspire V launch dynamics"
** At least 8 brokerages cut PT on stock
** Co posts Q2 sales of $217.1 mln, above analyst' est. of $214.3 - data compiled by LSEG
** Co reports Q2 adjusted EPS of 45 cents, above analyst' est of 21 cents - LSEG
** As of last close, stock down 30% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))